MedPath
FDA Approval

LOPREEZA

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 25, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Norethisterone(0.5 mg in 1 1)
Estradiol(1 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Amneal Pharmaceuticals of New York, LLC

Amneal Pharmaceuticals NY LLC

123797875

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LOPREEZA

Product Details

NDC Product Code
69238-1610
Application Number
NDA020907
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
July 25, 2018
Code: 9S44LIC7OJClass: ACTIBQuantity: 0.5 mg in 1 1
EstradiolActive
Code: 4TI98Z838EClass: ACTIBQuantity: 1 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
COPOVIDONE K25-31Inactive
Code: D9C330MD8BClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
TRIACETINInactive
Code: XHX3C3X673Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
© Copyright 2025. All Rights Reserved by MedPath